000			01947 a2200505 4500
005			20250517033640.0
264		0	_c20160510
008			201605s 0 0 eng d
022			_a1873-7064
024	7		_a10.1016/j.neuropharm.2015.05.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aLitim, Nadhir
245	0	0	_aThe 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. _h[electronic resource]
260			_bNeuropharmacology _cOct 2015
300			_a86-94 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a3,4-Dihydroxyphenylacetic Acid _xmetabolism
650	0	4	_a5-alpha Reductase Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDihydrotestosterone _xblood
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopamine Plasma Membrane Transport Proteins _xmetabolism
650	0	4	_aDopaminergic Neurons _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDutasteride _xpharmacology
650	0	4	_aFinasteride _xpharmacology
650	0	4	_aHomovanillic Acid _xmetabolism
650	0	4	_aMPTP Poisoning _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aPars Compacta _xdrug effects
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aTestosterone _xblood
650	0	4	_aTime Factors
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
650	0	4	_aVesicular Monoamine Transport Proteins _xmetabolism
700	1		_aBourque, Mélanie
700	1		_aAl Sweidi, Sara
700	1		_aMorissette, Marc
700	1		_aDi Paolo, Thérèse
773	0		_tNeuropharmacology _gvol. 97 _gp. 86-94
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2015.05.015 _zAvailable from publisher's website
999			_c24931723 _d24931723